Extranodal NK/T-cell lymphoma: updates in biology and management strategies

Publication date: Available online 3 July 2018Source: Best Practice & Research Clinical HaematologyAuthor(s): Motoko Yamaguchi, Masahiko Oguchi, Ritsuro SuzukiAbstractExtranodal NK/T-cell lymphoma, nasal type (ENKL), is a rare lymphoma subtype of peripheral T/NK-cell lymphoma that is very common in East Asia and Latin America. Two-thirds of patients have localized disease in the nasal cavity or adjacent sites. Large retrospective studies have revealed the clinicopathologic features of ENKL patients, identified risk factors for short survival time, and developed prognostic models. Next-generation sequencing studies have provided a comprehensive list of recurrent mutations in ENKL. Since the early 2000s, disease-specific therapeutic approaches have been developed, and the standard of care for ENKL has markedly changed. Non-anthracycline-containing chemotherapy with or without radiotherapy is the current standard approach for ENKL treatment. Emerging therapies, including the use of immune checkpoint inhibitors, are being investigated.
Source: Best Practice and Research Clinical Haematology - Category: Hematology Source Type: research